Fri, Mar 6, 2015, 12:07 PM EST - U.S. Markets close in 3 hrs 53 mins


% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • rajuramas rajuramas Oct 22, 2010 2:57 PM Flag

    MNTA earnings for Q3 (potential scenario)

    From posted by 10nisman..

    Per page 14 of NVS Q3 press release, Sandoz R&D Expense in Q3 2010 was 6% of net sales or $131M versus Q3 2009 R&D expense of 8.2% of net sales or $152M. The 2.2% decline was "due to the recovery of co-development expenses from an external partner as well as continued productivity savings."

    Assuming the vast majority of the 2.2% R&D savings on Q3 2010 net sales (or $47.9 million) savings is due to MNTA co-development reimbursement, then it should be possible to work backwards to determine gross profit on mLovenox and potential earnings received by MNTA.

    Assuming $45 million of the $47.9 million is MNTA co-development reimbursement than working backwards we should be able to determine an approximate gross profit percentage for mLovenox and potential MNTA Q3 earnings. (MNTA co-development reimbursement could be greater than the $47.9 million savings however tried to error on the conservative side).

    Revenue $292M
    Less COGS: (92M)
    Gross Margin: $200M
    45% MNTA share = $90M of which 50% is paid to Sandoz/NVS for Reimbursement of co-development expenses.

    Q3 MNTA Earnings
    mLovenox: $45M (net of co-development reimbursement)
    mLov Milestone: 5M
    Total Revenue: $50M
    Quarterly burn: -$16M
    Profit before taxes: $34M
    Taxes: -$12M
    NOL: $12M
    Q3 net income: $34M
    Q3 Fully diluted EPS (assuming 50M shares): $0.68 per share

    SortNewest  |  Oldest  |  Most Replied Expand all replies
14.50-0.17(-1.16%)12:06 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.